Thermo Fisher's Oncomine Lung Cell-Free DNA Assay

Jul 07, 2016

Thermo Fisher Scientific has launched its Oncomine Lung Cell-Free DNA (cfDNA) assay. The assay is designed to target mutations in non-small cell lung cancer samples derived from circulating cfDNA in blood. It contains gene targets, such as EGFR and KRAS, and enables analysis with as little as one nanogram of initial sample or samples collected over time from the same subject. The Oncomine Lung cfDNA assay shows 90 percent sensitivity and more than 98 percent specificity at 0.1 percent limit of detection, the company said.

More Like This

Jun 28, 2017

Canopy Biosciences Gene Expression Analysis Service

Canopy Biosciences has launched a service for high-throughput gene-expression analysis. Based on the NanoString nCounter platform, the service works with a large array of sample types, including formalin-fixed paraffin-embedded tissue. Canopy has paired this service with genome editing capabilities enabled by its recent licensing of TUNR flexible gene editing technology from Washington University in St. Louis and Johns Hopkins University. The new service features a web-based ordering tool, through which researchers can choose one of NanoString's pre-made gene panels or design their own custom panel. Each panel enables the simultaneous measurement of over 700 genes, Canopy said.

Jun 28, 2017

Roche Harmony NIPT 22q11.2 deletion

Roche has added 22q11.2 deletion testing to the Harmony Prenatal Test's menu, allowing laboratories and physicians using the test to screen for 22q11.2 deletion syndrome, which is associated with heart defects, poor immune system function, cleft palate, and delayed development. The 22q11.2 deletion is estimated to occur in 1 out of every 2,000 to 4,000 live births. 

Jun 28, 2017

Bioarray PGS+PGD Single Biopsy Kit

Bioarray has launched its PGS+PGD Single Biopsy kit which screens aneuploidies and identifies embryos with pathological mutation from a single biopsy sample. The kit uses next-generation sequencing technology and bioinformatics analysis to determine whether an embryo carries aneuploidies, such as trisomy of chromosome 21, and allow for users to reject embryos affected by the mutation and/or select those not affected. Users can expect results to be processed within three to five days.

Jun 27, 2017

DNANexus Mosaic Microbiome Research Platform

Working with the Janssen Human Microbiome Institute, DNANexus has introduced Mosaic, a cloud-based informatics platform to support collaboration on research into the human microbiome. DNANexus is positioning Mosaic as a "virtual ecosystem and innovation accelerator" for academic medical centers, biotech and pharmaceutical companies, technology vendors, and government regulators.

Jun 27, 2017

SeraCare iQ NGS QC Management v2

SeraCare Life Sciences has launched version two of its iQ NGS QC Management software. The software supports laboratories' workflows from sample preparation to variant calling enabling lab managers to review and assess run performance, determine run pass or fail status, and identify potential sources of assay drift that could cause problems, according to the company. The software also generates a report that can be used for audits or inspections. The software integrates with existing data systems like Illumina BaseSpace and LIMS.

Jun 26, 2017

Oxford Nanopore PCR-cDNA and Direct cDNA Sequencing Kits

Oxford Nanopore Technologies has launched a PCR-cDNA Sequencing kit and a Direct cDNA Sequencing to prepare cDNA for nanopore sequencing. The PCR-cDNA kit requires a minimum input of 50 nanograms of RNA and the Direct cDNA kit requires at least 250 nanograms of RNA. Both kits can be used on any RNA with a polyA tail, and both are compatible with barcoding kits to multiplex samples.

Jun 26, 2017

Premaitha Health Updated Iona Test

Premaitha Health has updated its Iona noninvasive prenatal test, which now includes the first trimester combined test risk score as an option in its software. The company said that it completed a validation study to show that the Iona test in combination with the first trimester combined screen was as accurate as estimating prior risk using maternal age.

Jun 26, 2017

BloodCenter of Wisconsin's Diagnostic Laboratories hematology test panels

BloodCenter of Wisconsin's Diagnostic Laboratories launched seven hematology genetics test panels. The new panels include nonmalignant hematology disorders, such as platelet function disorders, inherited thrombocytopenia, and congenital neutropenias.  

Jun 22, 2017

Bio-Rad Droplet Digital PCR-Based Assays

Bio-Rad Laboratories has launched droplet digital PCR Genome Edit Detection assays, which can characterize edits generated by CRISPR-Cas9 or other genome editing tools. The assays use ddPCR technology which increases the signal-to-noise ratio, allowing users to quantify extremely rare edits, even those with frequencies of 0.5 percent and from as little as 5 nanograms of genomic DNA. Users can expect to obtain results within one day.

Jun 21, 2017

Children's Hospital Los Angeles OncoKids

Children's Hospital Los Angeles has launched OncoKids, a next-generation sequencing-based panel that detects mutations, gene amplification, and gene fusions for a full range of pediatric cancers including leukemias, bone and soft tissue tumors, and brain tumors. It only requires a small amount of DNA and RNA (20ng) isolated from fresh, frozen, or formalin-fixed paraffin-embedded tissue. The test was developed in collaboration with Thermo Fisher Scientific and uses the Ion Torrent S5 sequencing platform and Ion AmpliSeq technology.

Jun 19, 2017

Thermo Fisher Scientific ISQ EC Single Quadrupole Mass Spectrometer, MabPac RP 1mm Columns

Thermo Fisher Scientific has launched a new mass spectrometer and new chromatography columns. The ISQ EC Single Quadrupole mass spectrometer integrates with existing ion chromatography and HPLC systems, and the Chromeleon Chromatography Data Software has instrument control for the new mass spec embedded. The MabPac RP 1mm columns are designed for analyzing monoclonal antibodies, fragments, variants, antibody drug conjugates, and proteins using high-performance reversed-phase chromatography. They can operate with small sample volumes at low flow rates for direct injection into a mass spectrometer.

Jun 16, 2017

Premaitha Sage Prenatal Screening Solution

Premaitha Health has launched Sage, a noninvasive prenatal testing solution. The test uses the latest technology to detect placental DNA in maternal blood sample, and uses the company's cloud-based bioinformatics analysis to allow laboratories to upload sequencing data files to the cloud for remote analysis. The panel includes full chromosome analysis. The testing will be available through Yourgene Bioscience Singapore, which was acquired by Premaitha in March.

Jun 15, 2017

TATAA Biocenter GrandPeformance Assays

TATAA Biocenter has launched GrandPerformance assays for expression profiling single circulating tumor cells. The assays' workflow is based on preamplification allowing precise measurements of 96 specific expression markers per cell. They are also optimized for single-cell sensitivity.

Jun 15, 2017

Integrated DNA RhAmp SNP Genotyping Solution

Integrated DNA Technologies has launched its rhAmp SNP Genotyping system to enable researchers to make quick, confident, and cost-effective SNP calls. The system is a single-tube assay that uses a unique RNase H2/DNA polymerase two-enzyme system coupled with RNA-DNA hybrid primers to eliminate non-specific amplification. It also uses primer dimer formation, can be fully automated, and is designed to work on all leading commercially available qPCR platforms.

Jun 14, 2017

Bio-Rad CFX Maestro Software

Bio-Rad Laboratories has launched CFX Maestro Software for CFX Real-Time instruments. It is a complete workflow solution for real-time PCR data collection and analysis that enables researchers to set up and run qPCR experiments with ease, the company said. The software includes tools to support reference gene selection, efficiency-corrected relative normalization, data visualization, statistics, and multiplate analysis.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.